These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 352329)

  • 21. [Immunological problems in oncology (author's transl)].
    Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
    Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-specific, cell-mediated immune resistance to autochthonous tumors.
    Kikuchi K; Kikuchi Y; Phillips ME; Southam CM
    Cancer Res; 1972 Mar; 32(3):516-21. PubMed ID: 5062227
    [No Abstract]   [Full Text] [Related]  

  • 23. Accelerated growth of syngeneic tumors in mice treated with methylcholanthrene.
    Lill PH; Jessup JM; Kripke ML
    Int J Cancer; 1978 Apr; 21(4):511-5. PubMed ID: 669850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour immunology.
    Heslop BF
    Aust N Z J Surg; 1977 Oct; 47(5):688-93. PubMed ID: 305776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphocyte-mediated immune responses in neoplasia.
    Pilch YH; Golub SH
    Am J Clin Pathol; 1974 Aug; 62(2):184-211. PubMed ID: 4602086
    [No Abstract]   [Full Text] [Related]  

  • 26. [Growth control of experimental tumour. I. Host protection against tumour by previous inoculation of plasmatic membrane of tumour cell (author's transl)].
    Gomes RM; Preza PA; Bastos VC; Coelho MG; Kovary K; de Castro Faria H
    Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):229-35. PubMed ID: 725135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical promise of tumour immunology.
    Scott AM; Cebon J
    Lancet; 1997 May; 349 Suppl 2():SII19-22. PubMed ID: 9164443
    [No Abstract]   [Full Text] [Related]  

  • 28. IMMUNITY AGAINST TUMOUR TISSUE.
    KOLDOVSKY P
    Neoplasma; 1965; 12():113-8. PubMed ID: 14320328
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor immunology.
    Transplant Proc; 1975 Mar; 7(1 Suppl 1):473-555. PubMed ID: 1053512
    [No Abstract]   [Full Text] [Related]  

  • 30. Experimental mouse tumour models: what can be learnt about human cancer immunology?
    Dranoff G
    Nat Rev Immunol; 2011 Dec; 12(1):61-6. PubMed ID: 22134155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor immunology--three decades in review.
    Brodt P
    Annu Rev Microbiol; 1983; 37():447-76. PubMed ID: 6227278
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunity in malignant disease.
    Fairley GH
    Trans Med Soc Lond; 1968; 84():96-109. PubMed ID: 5708160
    [No Abstract]   [Full Text] [Related]  

  • 33. Release of a cytotoxic factor by murine spleen cells in the presence of a tumour allograft.
    Vaillier D; Donner M; Burg C
    Experientia; 1972 Nov; 28(11):1352-3. PubMed ID: 4638919
    [No Abstract]   [Full Text] [Related]  

  • 34. EFFECT ON TUMOUR GROWTH IN SYNGENEIC RECIPIENTS OF ANTIBODIES AGAINST TUMOUR-SPECIFIC ANTIGENS IN METHYLCHOLANTHRENE-INDUCED MOUSE SARCOMAS.
    MOLLER G
    Nature; 1964 Nov; 204():846-7. PubMed ID: 14235705
    [No Abstract]   [Full Text] [Related]  

  • 35. Appropriateness of animal models for the immunology of human cancer.
    Rapp HJ
    Cancer Res; 1979 Oct; 39(10):4285-7. PubMed ID: 476659
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous tumor regression. Experimental aspects.
    McLaughlin AP; Gittes RF
    Urology; 1974 May; 3(5):544-51. PubMed ID: 4133855
    [No Abstract]   [Full Text] [Related]  

  • 37. IMMUNITY AGAINST CANCEROGEN-INDUCED TUMOURS.
    BUBENIK J
    Neoplasma; 1965; 12():119-24. PubMed ID: 14320329
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunology and immunotherapy of lung cancer--experimental and clinical investigations (author's transl)].
    Micksche VM
    Wien Klin Wochenschr Suppl; 1978; 90():1-28. PubMed ID: 362733
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumour immunology and the gut.
    Calman KC
    Gut; 1975 Jun; 16(6):490-9. PubMed ID: 50255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of delayed hypersensitivity to human tumor cells with a human monoclonal anti-idiotypic antibody.
    Austin EB; Robins RA; Baldwin RW; Durrant LG
    J Natl Cancer Inst; 1991 Sep; 83(17):1245-8. PubMed ID: 1870151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.